Search hospitals > Pennsylvania > Lancaster
Lancaster General Hospital
Claim this profileLancaster, Pennsylvania 17601
Global Leader in Breast Cancer
Global Leader in Heart Failure
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
169 reported clinical trials
17 medical researchers
Summary
Lancaster General Hospital is a medical facility located in Lancaster, Pennsylvania. This center is recognized for care of Breast Cancer, Heart Failure, Cancer, Lung Cancer, Adenocarcinoma and other specialties. Lancaster General Hospital is involved with conducting 169 clinical trials across 223 conditions. There are 17 research doctors associated with this hospital, such as Sandeep Bansal, Caitlin S. Farabaugh, Pamela Boimel, and Ami P. Jhaveri.Area of expertise
1Breast Cancer
Global LeaderStage II
ER positive
HER2 negative
2Heart Failure
Global LeaderTop PIs
Sandeep BansalGSK Investigational Site1 year of reported clinical research
Studies Asthma
Studies Chronic Obstructive Pulmonary Disease
16 reported clinical trials
21 drugs studied
Caitlin S. FarabaughLancaster General Ann B Barshinger Cancer Institute7 years of reported clinical research
Studies Endometrioid Carcinoma
Studies Endometrial Cancer
4 reported clinical trials
10 drugs studied
Pamela BoimelLancaster General Hospital5 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
3 reported clinical trials
9 drugs studied
Ami P. JhaveriLancaster General Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
2 reported clinical trials
4 drugs studied
Clinical Trials running at Lancaster General Hospital
Breast Cancer
Heart Failure
Ovarian Cancer
Obesity
Cardiovascular Disease
Non-Hodgkin's Lymphoma
Deep Vein Thrombosis
Ventricular Tachycardia
Cardiomyopathy
Stroke
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This study is evaluating whether a combination of drugs may help treat breast cancer.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lancaster General Hospital?
Lancaster General Hospital is a medical facility located in Lancaster, Pennsylvania. This center is recognized for care of Breast Cancer, Heart Failure, Cancer, Lung Cancer, Adenocarcinoma and other specialties. Lancaster General Hospital is involved with conducting 169 clinical trials across 223 conditions. There are 17 research doctors associated with this hospital, such as Sandeep Bansal, Caitlin S. Farabaugh, Pamela Boimel, and Ami P. Jhaveri.